Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNot eating enough on Mounjaro is more common than people expect, and it carries real risks. Tirzepatide suppresses appetite significantly — clinical trial data from SURMOUNT-1, published in the New England Journal of Medicine, recorded average reductions in body weight of around 20% over 72 weeks, driven in large part by a sustained drop in hunger. That appetite reduction is the point. But when it goes too far, and meals shrink to almost nothing, the body starts to struggle in ways that undermine both health and the treatment itself. Tirzepatide is a prescription-only medicine; a prescriber assesses your suitability and guides how to eat alongside it, not just whether to take it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works by activating both GIP and GLP-1 receptors, two gut-hormone pathways that together reduce appetite, slow the movement of food through the stomach and improve the body's sense of fullness. The NHS describes this dual mechanism on its tirzepatide medicines page. In practice, many people find that meals they would once have finished easily now feel filling after a few bites. That is the mechanism doing its job.
The problem emerges when appetite suppression tips from helpful to excessive. A plate half-finished becomes a plate barely touched. Skipping meals starts to feel easy, even natural. This is the misconception worth naming and gently setting aside: lighter eating is the goal, not near-fasting. Very low calorie intake (regularly falling below roughly 800 kcal for most adults) puts the body into a state of energy stress that tirzepatide was never designed to produce.
The starting dose of 2.5mg exists specifically to let the body adjust; appetite suppression typically intensifies after each dose increase. Keeping a loose mental note of whether you're actually eating across the day, rather than just not feeling hungry, is a practical habit worth building from the first pen onwards, and our guide on what happens if you don't eat on Mounjaro explains why that matters in more detail. If you're curious how the injection itself works in practice, the full guide to Mounjaro injections covers the mechanics.
When calorie intake falls too low for too long, the body doesn't draw solely on fat stores. It turns to muscle as a fuel source too. Losing lean mass reduces strength, slows the metabolism and makes it harder to maintain weight loss once treatment ends. This is the physiological argument for eating enough protein, not dieting advice, but basic biology.
Beyond muscle, consistent under-eating on Mounjaro creates real risks of micronutrient deficiency. B vitamins, iron, calcium, vitamin D and zinc are all harder to obtain at very low food volumes. Fatigue that people sometimes attribute to the medicine can, in part, reflect inadequate intake. Dizziness, particularly on standing, can follow from both caloric restriction and dehydration, which is itself worsened by gastrointestinal side effects such as nausea or vomiting that can accompany dose increases.
The NHS healthy weight guidance consistently emphasises that sustainable calorie reduction should sit alongside balanced nutrition, not replace it. On tirzepatide, where appetite cues are blunted, that balance requires a little more conscious attention than usual. Practical strategies include eating protein first at every meal, keeping nutrient-dense foods visible and easy to reach, and not skipping meals entirely even when hunger is absent. If you find your appetite swinging the other way, our guide to what happens if you overeat on Mounjaro covers what to expect and how to manage it, and if you're wondering about the effects of a particularly large meal, our page on what happens if you eat too much on Mounjaro goes into that in more detail.
There is a difference between eating less than you used to (expected, appropriate) and eating so little that daily life is affected. Warning signs that warrant a clinical conversation include: persistent light-headedness, weakness that stops you exercising or concentrating, visible muscle wasting, hair thinning, or food intake so minimal that you cannot recall a full meal in recent days.
A prescriber can do several things. They can assess whether the current dose is proportionate, consider whether the titration schedule should slow down, and review whether any co-prescribed medicines or existing conditions are contributing. They may recommend working with a dietitian. None of this requires waiting until a formal review date; if something feels wrong, the right step is to make contact. It is also worth knowing that not storing Mounjaro correctly in the fridge can affect how well the medicine works, so checking your storage routine is a sensible part of any clinical conversation. At nume, prescribers are available seven days a week for aftercare, and every repeat order is clinically re-reviewed before dispatch, the process is described in more detail on the about us page. Questions about cost or what treatment involves can be found on the Mounjaro prices page.
No dosing decision (including whether to stay at the current dose longer or pause a planned increase) should be made without clinical input. The Patient Information Leaflet included with each pen and the prescribing team are the right sources for personalised guidance. If you have broader questions about treatment, the faqs page covers many of the most common ones. When you're ready to speak to a prescriber about whether Mounjaro is right for you, starting a free consultation is the first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.